Zorzela Liliane M 201501 PhD.pdf
more than 60 minutes and did not have any serious events (i.e., PRIS or cardiac arrest)
associated with it.
Through this work we developed PRISMA Harms, an international reporting guideline to
improve harms reporting in SRs.
Further, we documented serious AEs associated with propofol infusion in children and the
relevance of including non-‐randomized and unpublished studies in SRs of AEs, providing both
clinical and methodological significant information.